deltatrials
Recruiting EARLY_PHASE1 INTERVENTIONAL 1-arm NCT05098184

A Study of GC101 TIL in Advanced Melanoma (10hospital)

A Clinical Study to Evaluate the Safety and Efficacy of Autologous Tumor Infiltrating Lymphocytes Injection in Patients With Advanced Melanoma

Sponsor: Shanghai 10th People's Hospital

Conditions Advanced Melanoma Effects of Immunotherapy Treatment Side Effects Tumor Infiltrating Lymphocyte
Interventions Tumor Infiltrating Lymphocyte
Updated 9 times since 2021 Last updated: Dec 4, 2025 Started: Sep 26, 2021 Primary completion: Sep 25, 2026 Completion: Sep 25, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05098184, this EARLY_PHASE1 trial focuses on Advanced Melanoma and Effects of Immunotherapy and remains actively recruiting participants. Sponsored by Shanghai 10th People's Hospital, it has been updated 9 times since 2021, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Nov 2021 – ~Jul 2022 · 8 months · monthly snapshotRecruiting~Jul 2022 – ~Sep 2022 · 2 months · monthly snapshot~Sep 2022 – ~Jan 2023 · 4 months · monthly snapshot~Jan 2023 – ~May 2024 · 16 months · monthly snapshotRecruiting~May 2024 – ~Jul 2024 · 2 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Feb 2025 · 5 months · monthly snapshotRecruiting~Feb 2025 – ~Jan 2026 · 11 months · monthly snapshotRecruiting~Jan 2026 – present · 7 months · monthly snapshotRecruiting

Change History

9 versions recorded

  1. Jan 2026 — Present [monthly]

    Recruiting EARLY_PHASE1

  2. Feb 2025 — Jan 2026 [monthly]

    Recruiting EARLY_PHASE1

  3. Sep 2024 — Feb 2025 [monthly]

    Recruiting EARLY_PHASE1

  4. Jul 2024 — Sep 2024 [monthly]

    Recruiting EARLY_PHASE1

  5. May 2024 — Jul 2024 [monthly]

    Recruiting EARLY_PHASE1

▶ Show 4 earlier versions

  1. Jan 2023 — May 2024 [monthly]

    Recruiting EARLY_PHASE1

  2. Sep 2022 — Jan 2023 [monthly]

    Recruiting EARLY_PHASE1

  3. Jul 2022 — Sep 2022 [monthly]

    Recruiting EARLY_PHASE1

  4. Nov 2021 — Jul 2022 [monthly]

    Recruiting EARLY_PHASE1

    First recorded

Sep 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Shanghai 10th People's Hospital
  • Shanghai Juncell Therapeutics
Data source: Shanghai Juncell Therapeutics

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations